Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease -: Results from a German national survey

被引:87
|
作者
Langhorst, J
Anthonisen, IB
Steder-Neukamm, U
Lüdtke, R
Spahn, G
Michalsen, A
Dobos, GJ
机构
[1] Kliniken Essen Mitte, Dept Internal Med, D-45276 Essen, Germany
[2] Univ Duisburg Essen, Dept Gastroenterol & Hepatol, Duisburg, Germany
[3] German Crohns & Ulcerat Colitis Assoc, Leverkusen, Germany
[4] Karl & Veronica Carstens Fdn, Essen, Germany
关键词
alternative medicine; complementary medicine; Crohn's disease; ulcerative colitis;
D O I
10.1097/01.MIB.0000160771.71328.6c
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Previous studies have suggested that inflammatory bowel disease (IBD) patients rank high among users of complementary and alternative medicine (CAM). To further elucidate this phenomenon, we sent questionnaires to a large sample of IBD patients in Germany to determine the patterns and predictors of their CAM use. Methods: Pretested 73-item questionnaires were mailed to a randomly selected representative sample of 1000 1 BD patients from the approximately 16,000 members and associates of the German Crohn's and Colitis Association. Predictors of CAM use were evaluated by logistic regression models. Results: Completed questionnaires were returned by 684 patients (female patients, 61.4%; Crohn's disease patients, 58.3%; ulcerative colitis patients, 38.2%). Of the 671 adult respondents, 344 (51.3%) had experience with CAM, and significantly more of the ulcerative colitis patients (59.8%) than the Crohn's disease patients (48.3%) had experience with CAM. There was no difference by gender. Homeopathy (52.9%) and herbal medicine (43.6%) were the most commonly used types of CAM. The most frequent personal reasons for CAM use were the search for an "optimum treatment" (78.9%) and the wish to stop taking steroids (63.8%). Using logistic regression, we found that total cortisone intake (P = 0.0077), but not duration of disease, was a strong predictor of CAM use. Other predictors were experience with psychosomatic and psychotherapeutic support (P = 0.0029), relaxation techniques (P = 0.0284), an academic education (P = 0.0173), a diet utilizing whole grains (P = 0.0123), and a normal body weight (P = 0.0215). Although 80% of patients indicated that they were interested in using CAM in the future, only 24.7% felt sufficiently informed about it. Conclusions: More than 50% of a large group of German IBD patients had used CAM. Prolonged or intensive steroid treatment, an academic education, active ways of coping, and a health-conscious life-style are associated with CAM use. Given the potential side effects and interactions, the treating physician should focus on thorough information about the benefits and limitations of conventional and complementary treatment options, especially for IBD patients who have received prolonged or intensive steroid treatment.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 50 条
  • [41] Older Age and Steroid Use Are Associated with Increasing Polypharmacy and Potential Medication Interactions Among Patients with Inflammatory Bowel Disease
    Parian, Alyssa
    Ha, Christina Y.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (06) : 1392 - 1400
  • [42] Use of complementary and alternative therapies by patients self-reporting arthritis or rheumatism: Results from a nationwide Canadian survey
    Fautrel, B
    Adam, V
    St-Pierre, Y
    Joseph, L
    Clarke, AE
    Penrod, JR
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (11) : 2435 - 2441
  • [43] Inflammatory Bowel Disease Patients' Perspectives during COVID-19 Pandemic: Results from a Portuguese Survey
    Reves, Joana Branco
    Frias-Gomes, Catarina
    Morao, Barbara
    Nascimento, Catarina
    Palmela, Carolina
    Fidalgo, Catarina
    Ramos, Lidia Roque
    Sampaio, Ana
    Gloria, Luisa
    Cravo, Marilia
    Torres, Joana
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2022, 29 (05) : 339 - 347
  • [44] Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients
    Selinger, Christian P.
    Parkes, Gareth C.
    Bassi, Ash
    Limdi, Jimmy K.
    Ludlow, Helen
    Patel, Pritash
    Smith, Melissa
    Saluke, Santosh
    Ndlovu, Zandile
    George, Becky
    Saunders, John
    Adamson, Mark
    Fraser, Aileen
    Robinson, Jenna
    Donovan, Fiona
    Parisi, Ioanna
    Tidbury, Jude
    Gray, Lynn
    Pollok, Richard
    Scott, Glyn
    Raine, Tim
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (09) : 1009 - 1018
  • [45] Validation and First Results of the German QUOTE-IBD to Measure Quality of Care from the Perspective of Patients with Inflammatory Bowel Disease
    Lehmann, M.
    Walther, M.
    Ulitzsch, S.
    Thomas, A.
    Haeuser, W.
    Stallmach, A.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (02): : 196 - +
  • [46] Patients' perceptions of faecal calprotectin testing in inflammatory bowel disease: results from a prospective multicentre patient-based survey*
    Kalla, Rahul
    Boyapati, Ray
    Vatn, Simen
    Hijos, Gonzalo
    Crooks, Benjamin
    Moore, Gregory Thomas
    Hall, Veronica
    Lipscomb, George
    Gomollon, Fernando
    Jahnsen, Jorgen
    Singh, Salil
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (12) : 1437 - 1442
  • [47] Use of complementary and alternative medical therapies among racial and ethnic minority adults: Results from the 2002 National Health Interview Survey
    Graham, Robert E.
    Ahn, Andrew C.
    Davis, Roger B.
    O'Connor, Bonnie B.
    Eisenberg, David M.
    Phillips, Russell S.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2005, 97 (04) : 535 - 545
  • [48] Predicting Pre-emptive Discussions of Biologic Treatment: Results from an Openness and Preference Survey of Inflammatory Bowel Disease Patients and Their Prescribers
    M. Furaha Kariburyo
    Lin Xie
    Amanda Teeple
    Haoran Tan
    Michael Ingham
    Advances in Therapy, 2017, 34 : 1398 - 1410
  • [49] Predicting Pre-emptive Discussions of Biologic Treatment: Results from an Openness and Preference Survey of Inflammatory Bowel Disease Patients and Their Prescribers
    Kariburyo, M. Furaha
    Xie, Lin
    Teeple, Amanda
    Tan, Haoran
    Ingham, Michael
    ADVANCES IN THERAPY, 2017, 34 (06) : 1398 - 1410
  • [50] Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 National Health Interview Survey
    Nahin, Richard L.
    Byrd-Clark, Danita
    Stussman, Barbara J.
    Kalyanaraman, Nilesh
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 12